Postpartum Hemorrhage: From Proven Tools to Real-World Impact
AlignMNH shared a post on LinkedIn:
“Excessive bleeding after childbirth, or postpartum hemorrhage (PPH), remains a leading cause of maternal death worldwide—responsible for nearly 45,000 deaths in 2023.
A new commentary in BJOG—co-authored by our colleague Lisa Noguchi — reflects on progress since the launch of the WHO Roadmap to Combat PPH (2023–2030) and outlines why urgent, coordinated action is needed to save women’s lives.
Key highlights:
- Global maternal deaths have declined by 41% since 2000, but progress remains uneven—women in sub-Saharan Africa and South Asia continue to face disproportionate risk.
- Proven solutions—like uterotonics, tranexamic acid, and the PPH treatment bundle—are still underused due to policy, financing, and supply chain gaps.
- The Roadmap has catalyzed important gains: rapid uptake of the E-MOTIVE trial evidence into WHO guidelines, adoption of PPH bundles in multiple countries, and the launch of the first World PPH Day to sustain global advocacy.
But systemic inequities, fragile financing, and geopolitical challenges still stall progress.
The message is clear: we have the tools, evidence, and solutions. What matters now is translating them into sustained action everywhere.”
Title: World Postpartum Haemorrhage Day: Renewing the Global Call to End Deaths From Postpartum Haemorrhage

Read the full article here.
Stay informed with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series